Injectable hydrogel uses dual mechanisms for customizable drug release, achieving burst, linear, or delayed patterns over two weeks, with potential to reduce injection frequency.
Integra LifeSciences Holding Corporation IART has announced the publication of a new economic study assessing the budget impact of switching treatment from fibrin glue to DuraSeal Polyethylene Glycol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback